TGF-beta 1 induced fibroblast proliferation is mediated by the FGF-2/ERK pathway
- PMID: 22652804
- DOI: 10.2741/4077
TGF-beta 1 induced fibroblast proliferation is mediated by the FGF-2/ERK pathway
Abstract
Pulmonary fibrosis, defined as the accumulation of connective tissue in the lungs, is a severe and often fatal form of interstitial lung disease. Transforming growth factor-beta (TGF-beta) is a powerful activator of connective tissue synthesis and fibroblast proliferation in the lung, and a critical paracrine signal for the development of pulmonary fibrosis. To investigate signaling pathways downstream of TGF- beta that contribute to lung fibrosis, TGF- beta stimulation of fibroblasts was replicated by treating NIH3T3 fibroblasts with conditioned medium (CM) from TGF- beta -treated type II alveolar epithelial cells (ATII cells). The data showed that fibroblast growth factor 2 (FGF-2) signaling is responsible for TGF-beta 1 CM-induced fibroblast proliferation, while it does not affect TGF-beta 1 CM-induced fibrotic differentiation. Moreover, fibroblast proliferation and differentiation induced by TGF- beta CM was totally abrogated by pretreatment of NIH3T3 cells with the specific ERK1/2 inhibitor, PD98059. These findings indicate that FGF-2 secreted by alveolar epithelial cells in response to TGF- beta 1 induces fibroblast proliferation and fibrotic activation through the ERK kinase pathway.
Similar articles
-
Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK.J Biol Chem. 2005 Dec 30;280(52):43000-9. doi: 10.1074/jbc.M510441200. Epub 2005 Oct 24. J Biol Chem. 2005. PMID: 16246848
-
Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2.Exp Mol Pathol. 2016 Aug;101(1):22-30. doi: 10.1016/j.yexmp.2016.04.003. Epub 2016 Apr 23. Exp Mol Pathol. 2016. PMID: 27112840 Free PMC article.
-
Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis.J Pathol. 2016 Oct;240(2):197-210. doi: 10.1002/path.4768. J Pathol. 2016. PMID: 27425145
-
Epithelial-mesenchymal interactions in fibrosis and repair. Transforming growth factor-β activation by epithelial cells and fibroblasts.Ann Am Thorac Soc. 2015 Mar;12 Suppl 1(Suppl 1):S21-3. doi: 10.1513/AnnalsATS.201406-245MG. Ann Am Thorac Soc. 2015. PMID: 25830829 Free PMC article. Review.
-
Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages.Curr Pharm Des. 2007;13(12):1247-56. doi: 10.2174/138161207780618885. Curr Pharm Des. 2007. PMID: 17504233 Review.
Cited by
-
Silver and gold nanoparticles as a novel approach to fight Sarcoptic mange in rabbits.Sci Rep. 2024 May 9;14(1):10618. doi: 10.1038/s41598-024-60736-w. Sci Rep. 2024. PMID: 38724594 Free PMC article.
-
MAPK phosphatase 1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution.J Clin Invest. 2024 Mar 21;134(10):e172826. doi: 10.1172/JCI172826. J Clin Invest. 2024. PMID: 38512415 Free PMC article.
-
Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention.Life (Basel). 2024 Feb 6;14(2):229. doi: 10.3390/life14020229. Life (Basel). 2024. PMID: 38398739 Free PMC article. Review.
-
Functional characterization of the dimeric form of PDGF-derived fusion peptide fabricated based on theoretical arguments.Sci Rep. 2024 Jan 10;14(1):1003. doi: 10.1038/s41598-024-51707-2. Sci Rep. 2024. PMID: 38200288 Free PMC article.
-
Emerging delivery approaches for targeted pulmonary fibrosis treatment.Adv Drug Deliv Rev. 2024 Jan;204:115147. doi: 10.1016/j.addr.2023.115147. Epub 2023 Dec 6. Adv Drug Deliv Rev. 2024. PMID: 38065244 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
